Skip to main content
SpringerLink
Log in

The Urologic Impact of Guillain–Barré Syndrome

  • Chapter
  • First Online:
Urological Care for Patients with Progressive Neurological Conditions

  • 353 Accesses

Abstract

Guillain–Barré Syndrome is an acute flaccid paralysis that is rapidly progressing. Neurologic decline continues for 12 hours to 4 weeks after symptom onset. Approximately 25% of patients develop acute urinary symptoms such as difficulty voiding or frank urinary retention. Longer term urinary symptoms include persistent overactive bladder and nocturia. Key urologic interventions include indwelling catheter during acute phase, particularly when patient is experiencing respiratory failure; intermittent catheterization for retention if patient has preserved hand function; voiding trial after neurologic recovery; and anticholinergics for persistent overactive bladder after recovery.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Guillain G. Radiculoneuritis with acellular hyperalbuminosis of the cerebrospinal fluid. Arch Neurol Psychiatr. 1936:975–90.

    Google Scholar 

  2. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36:123–33.

    Article  PubMed  Google Scholar 

  3. Yuki N, Hartung H-P. Guillain-Barré syndrome. N Engl J Med. 2012;366:2294–304.

    Article  CAS  PubMed  Google Scholar 

  4. Jacobs BC, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998;51:1110–5.

    Article  CAS  PubMed  Google Scholar 

  5. Frontera JA, da Silva IRF. Zika getting on your nerves? The association with the Guillain-Barré Syndrome. N Engl J Med. 2016;375:1581–2.

    Article  PubMed  Google Scholar 

  6. Lehmann HC, Hartung H-P, Kieseier BC, Hughes RAC. Guillain-Barré syndrome after exposure to influenza virus. Lancet Infect Dis. 2010;10:643–51.

    Article  PubMed  Google Scholar 

  7. Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet (London, England). 2016;388:717–27.

    Article  Google Scholar 

  8. Huizinga R, et al. Innate immunity to campylobacter jejuni in Guillain-Barré Syndrome. Ann Neurol. 2015;78:343–54.

    Article  CAS  PubMed  Google Scholar 

  9. McGonigal R, et al. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain. 2010;133:1944–60.

    Article  PubMed  Google Scholar 

  10. Hafer-Macko CE, et al. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol. 1996;39:625–35.

    Article  CAS  PubMed  Google Scholar 

  11. Sejvar JJ, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29:599–612.

    Article  PubMed  Google Scholar 

  12. Lichtenfeld P. Autonomic dysfunction in the Guillain-Barré syndrome. Am J Med. 1971;50:772–80.

    Article  CAS  PubMed  Google Scholar 

  13. van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology. 2013;80:1650–4.

    Article  PubMed  Google Scholar 

  14. Kuitwaard K, van Koningsveld R, Ruts L, Jacobs BC, van Doorn PA. Recurrent Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2009;80:56–9.

    Article  CAS  PubMed  Google Scholar 

  15. Fokke C, et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137:33–43.

    Article  PubMed  Google Scholar 

  16. Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol. 2004;148:200–5.

    Article  CAS  PubMed  Google Scholar 

  17. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27(Suppl):S21–4.

    Article  PubMed  Google Scholar 

  18. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol. 2008;7:939–50.

    Article  PubMed  Google Scholar 

  19. Ruts L, et al. Pain in Guillain-Barre syndrome: a long-term follow-up study. Neurology. 2010;75:1439–47.

    Article  CAS  PubMed  Google Scholar 

  20. van der Meché FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group N Engl J Med. 1992;326:1123–9.

    Google Scholar 

  21. Guillain-Barré syndrome Study Group, T. Plasmapheresis and acute Guillain-Barré syndrome. Neurology. 1985;35:1096–104.

    Article  Google Scholar 

  22. Sakakibara R, Hattori T, Kuwabara S, Yamanishi T, Yasuda K. Micturitional disturbance in patients with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 1997;63:649–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Sakakibara R, et al. Prevalence and mechanism of bladder dysfunction in Guillain-Barré Syndrome. Neurourol Urodyn. 2009;28:432–7.

    Article  PubMed  Google Scholar 

  24. Naphade PU, et al. Prevalence of bladder dysfunction, urodynamic findings, and their correlation with outcome in Guillain-Barre syndrome. Neurourol Urodyn. 2012;31:1135–40.

    Article  PubMed  Google Scholar 

  25. Khan F, Pallant JF, Ng L, Bhasker A. Factors associated with long-term functional outcomes and psychological sequelae in Guillain-Barre syndrome. J Neurol. 2010;257:2024–31.

    Article  CAS  PubMed  Google Scholar 

  26. Amatya, B., Khan, F., Whishaw, M. & Pallant, J. F. Guillain-Barre syndrome: prevalence and long-term factors impacting bladder function in an Australian community cohort.[Erratum appears in J Clin Neurol. 2013;9(4):289–90]. J Clin Neurol. 2013;9:144–50.

    Google Scholar 

  27. Wosnitzer MS, Walsh R, Rutman MP. The use of sacral neuromodulation for the treatment of non-obstructive urinary retention secondary to Guillain-Barré syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20:1145–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urology, Department of Surgery, Greenville Health System, Greenville, SC, USA

    Elizabeth V. Dray

Authors
  1. Elizabeth V. Dray
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Neurourology and Pelvic Reconstruction, Department of Urology, University of Michigan Medical School, Ann Arbor, MI, USA

    John T. Stoffel

  2. Division of Urology, Department of Surgery, Greenville Health System, Greenville, SC, USA

    Elizabeth V. Dray

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Dray, E.V. (2020). The Urologic Impact of Guillain–Barré Syndrome. In: Stoffel, J.T., Dray, E.V. (eds) Urological Care for Patients with Progressive Neurological Conditions. Springer, Cham. https://doi.org/10.1007/978-3-030-23277-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-23277-1_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-23276-4

  • Online ISBN: 978-3-030-23277-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation